Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00580255

Comparison Study of BNP and Thoracic Impedance Measurements on Arrhythmias

Does Elevated Brain Natriuretic Peptide (BNP) Reflect Changes in Thoracic Impedance Levels and Affect Occurrence of Atrial and Ventricular Arrhythmias?

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

It is hypothesized that elevated BNP level correlate with an elevated thoracic impedance/fluid index as measured separately by CRT-D devices and external impedance cardiography. Ultimately, it is also hypothesized that both BNP and thoracic impedance/fluid index measurements are predictive of atrial and ventricular arrhythmias.

Detailed description

The primary aim of this study: 1. To assess the correlation between elevated brain natriuretic peptide levels and elevated thoracic impedance/body fluid index as measured by selective biventricular resynchronization devices and an external impedance cardiography device. 2. Correlate impedance measurements and brain natriuretic levels with occurrence of atrial and ventricular arrhythmias as assessed by interrogation of biventricular devices.

Conditions

Timeline

Start date
2006-10-01
Primary completion
2006-11-01
Completion
2006-11-01
First posted
2007-12-24
Last updated
2017-06-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00580255. Inclusion in this directory is not an endorsement.